The lowest-priced, brand-new, unused, unopened, undamaged item in its original packaging (where packaging is applicable).Packaging should be the same as what is found in a retail store, unless the item is handmade or was packaged by the manufacturer in non-retail packaging, such as an unprinted box or plastic bag.See details for additional description.
This book deals with the key techniques and approaches that can be used to estimate the cost-effectiveness of health care interventions. It is a practical guide, using examples and encouraging the reader to apply the methods. A supporting website is available.
Andrew Briggs was appointed to the Lindsay Chair in Health Policy and Economic Evaluation in June 2005. Previously he held the position of Reader in Health Economics at the University of Oxford's Health Economic Research Centre (HERC). Karl Claxton holds an adjunct appointment at Harvard as an Assistant Professor of Health and Decision Sciences. He is part of a committee that appraises new and existing health care technologies and issues guidance for the NHS on the use of these technologies. He has also contributed to the Task Group which developed guidance for the appraisal of health technologies for NICE. He is co-editor of the Journal of Health Economics. Mark Sculpher is Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York. He has previously worked at the Health Economics Research Group at Brunel University, and in the Department of Clinical Epidemiology and Biostatistics at McMaster University in Canada. He is a member of the NICE Technology Appraisal Committee and he chaired NICE's Task Group on methods guidance for economic evaluation. He is also a member of the Commissioning Board for the NHS Health Technology Assessment programme. He is on the editorial boards of Medical Decision Making, Health Expectations and the Journal of Applied Health Economics and Policy.